Literature DB >> 6229173

Risk of side branch occlusion during coronary angioplasty.

B Meier, A R Gruentzig, S B King, J S Douglas, J Hollman, T Ischinger, F Aueron, K Galan.   

Abstract

To assess the risk of side branch occlusion during percutaneous transluminal coronary angioplasty (PTCA), 600 consecutive procedures were analyzed. On the basis of pre-PTCA angiograms of 557 patients in whom the balloon was actually inflated, 365 side branches in 302 patients (54% of patients) were deemed in jeopardy. A total of 122 side branches in 102 patients (18%) originated from the lesion segment itself, i.e., their take-off was narrowed (Group I, 33% of side branches at risk), whereas 243 side branches in 214 patients (38%) originated from the immediate vicinity of the stenosis in a way that they were subjected to temporary occlusion during balloon dilatation (Group II, 67% of side branches at risk). Patency of side branches was determined by consensus of 2 observers. Criteria for occlusion were disappearance, filling by collaterals, or stagnation of flow. After PTCA, 20 of 365 side branches (5%) were occluded and associated with chest pain in 5 patients, creatine kinase increase in 6, left anterior hemiblock, septal Q waves and transient atrial fibrillation in 1 and non-sustained ventricular tachycardia in 1 of the 20 patients. Exercise tolerance did not decrease. No local predilection for side branch occlusion was evident. Seventeen of 122 side branches (14%) occluded in Group I, compared with 3 of 243 (1%) in Group II (p less than 0.001). Thus, more than half of the patients who underwent PTCA had side branches at risk for iatrogenic occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6229173     DOI: 10.1016/0002-9149(84)90675-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Stenting of complex lesions: an overview.

Authors:  Usman Baber; Annapoorna S Kini; Samin K Sharma
Journal:  Nat Rev Cardiol       Date:  2010-09       Impact factor: 32.419

Review 2.  Recent perspective on coronary artery bifurcation interventions.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2014-02-14

3.  Acute complications of elective coronary angioplasty: a review of 500 consecutive procedures.

Authors:  G Steffenino; B Meier; L Finci; V Velebit; L von Segesser; B Faidutti; W Rutishauser
Journal:  Br Heart J       Date:  1988-02

4.  Unusual transplant renal angioplasty complication: case report.

Authors:  I D Weisman; A L Ney; J H Andrisevic; W Stanchfield; M D Odland; R C Andersen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

5.  Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention.

Authors:  Hafidh A Alhadi; Keith A A Fox
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

6.  Treatment of coronary de novo bifurcation lesions with DCB only strategy.

Authors:  Antonia Schulz; Telse Hauschild; Franz X Kleber
Journal:  Clin Res Cardiol       Date:  2014-02-14       Impact factor: 5.460

7.  Spontaneous recanalisation of side branches occluded during percutaneous transluminal coronary angioplasty.

Authors:  M F Shiu; A Singh
Journal:  Br Heart J       Date:  1985-08

8.  Myocardial salvage prior to emergency coronary bypass surgery for PTCA-induced coronary occlusion.

Authors:  U W Busch; U Pfeiffer; R Bauer; U Renner; R Babic; G Blümel G; H Blömer
Journal:  Tex Heart Inst J       Date:  1986-03

9.  A planned hybrid culotte stenting procedure in the setting of an acute STEMI.

Authors:  Chitradeep De; Medhat Zaher; Mayur Lakhani; Joseph T McGinn; Roberto Baglini; Duccio Baldari
Journal:  Cases J       Date:  2009-11-27

10.  Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial.

Authors:  Franz X Kleber; Harald Rittger; Josef Ludwig; Antonia Schulz; Detlef G Mathey; Michael Boxberger; Ralf Degenhardt; Bruno Scheller; Ruth H Strasser
Journal:  Clin Res Cardiol       Date:  2016-01-14       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.